Adult Cyclic Vomiting Syndrome Successfully Treated with Intranasal Sumatriptan

Kowalczyk, Monika; Parkman, Henry P.; Ward, Lawrence

doi:10.1007/s11606-009-1162-y

Cited by 17 publications

(14 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with CVS are usually treated with either antidepressants, antimigrainous or antiepileptic medications [17,[22][23][24]. However, this cohort of patients is unique in that the majority of patients were only treated symptomatically.…”

Section: Discussionmentioning

confidence: 99%

Cyclic vomiting syndrome in 28 patients

Lee

Abbott

Moodie

et al. 2012

European Journal of Gastroenterology & Hepatology

View full text Add to dashboard Cite

CVS is a debilitating illness with frequent attacks of prolonged duration. There is a high association with anxiety/depression as well as headaches. Antimigraine medication, β-blockers and antiepileptic treatment may be successful at attenuating attacks; however, in this long-term study, the prognosis of patients not treated with these medications was also good. Overall, 61.9% of patients showed a gradual improvement in symptoms and 23.8% had complete resolution after a mean of 7 years.

show abstract

Section: Discussionmentioning

confidence: 99%

Cyclic vomiting syndrome in 28 patients

Lee

Abbott

Moodie

et al. 2012

European Journal of Gastroenterology & Hepatology

View full text Add to dashboard Cite

show abstract

“…Treatment should be initiated at the earliest signs of nausea. Sumatriptan (a 5-hydroxytryptamine (HT)- 1 receptor antagonist) has been shown to have some efficacy in aborting the attacks during the prodromal phase,12 when administered, intranasally, subcutaneously or even orally, particularly in patients with a family history of migraine 34 35 49…”

Section: Treatmentmentioning

confidence: 99%

Cyclic vomiting syndrome: a case series and review of the literature

Shearer

Luthra

Ford

2016

Frontline Gastroenterol

View full text Add to dashboard Cite

show abstract

“…With the increased association between migraines and CVS, the concept of using medications that treat the former to help alleviate the latter has been considered. In one case report, a 47 year old male diagnosed with CVS had his symptoms remit successfully with intranasal sumatriptan [21]. In another case report, a 14 year old female with 18q syndrome (a rare genetic disorder involving the deletion of the long arm of chromosome 18) and previously diagnosed with pediatric-onset CVS was treated successfully with sumatriptan during her attacks [22].…”

Section: Methodsmentioning

confidence: 99%

Association of Marijuana Use and Cyclic Vomiting Syndrome

2012

View full text Add to dashboard Cite

Cannabis use has become one of the most commonly abused drugs in the world. It is estimated that each year 2.6 million individuals in the USA become new users and most are younger than 19 years of age. Reports describe marijuana use as high as 40–50% in male Cyclic Vomiting Syndrome patients. It is this interest in cannabis in the World, coupled with recognition of a cyclic vomiting illness associated with its chronic use that beckons a review of the most current articles, as well as a contribution from our own experiences in this area. The similarities we have demonstrated for both cannibinoid hyperemesis syndrome and cyclic vomiting make the case that cannibinoid hyperemesis syndrome is a subset of patients who have the diagnoses of cyclic vomiting syndrome and the role of marijuana should always be considered in the diagnosis of CVS, particularly in males.

show abstract

Adult Cyclic Vomiting Syndrome Successfully Treated with Intranasal Sumatriptan

Cited by 17 publications

References 15 publications

Cyclic vomiting syndrome in 28 patients

Cyclic vomiting syndrome in 28 patients

Cyclic vomiting syndrome: a case series and review of the literature

Association of Marijuana Use and Cyclic Vomiting Syndrome

Contact Info

Product

Resources

About